Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CellaVision ABCHIX:CEVIS 97 Shiller PE Ratio is 25.80 as of Aug. 24, 2026, which is 74% below its 10-year median of 100.64. GuruFocus rates CHIX:CEVIS with a GF Score™ of 97/100 and a GF Value™ of kr187.70. The stock has 2 warning signs investors should review. Among 311 Medical Devices & Instruments companies, CellaVision AB ranks worse than 59.16% on this metric.
As of today (2026-08-24), CellaVision AB's current share price is kr160.20. CellaVision AB's E10 for the quarter that ended in Jun. 2026 was kr6.21. CellaVision AB's Shiller PE Ratio for today is 25.80.
The historical rank and industry rank for CellaVision AB's Shiller PE Ratio or its related term are showing as below:
CHIX:CEVIs'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 22.81 Med: 100.64 Max: 184.21
Current: 31
During the past years, CellaVision AB's highest Shiller PE Ratio was 184.21. The lowest was 22.81. And the median was 100.64.
CHIX:CEVIs's Shiller PE Ratio is ranked worse than 59.16% of 311
companies
in the Medical Devices & Instruments industry
Industry Median: 27
vs CHIX:CEVIs: 31.00
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
CellaVision AB's adjusted earnings per share data for the three months ended in Jun. 2026 was kr1.370. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is kr6.21 for the trailing ten years ended in Jun. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
CellaVision AB (CHIX:CEVIs) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
CellaVision AB Shiller PE Ratio Related Terms
CellaVision AB Shiller PE Ratio Historical Data
* Premium members only.
The historical data trend for CellaVision AB's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CHIX:CEVIS vs ABT, SYK, MDT: Shiller PE Ratio Comparison
For the Medical Devices subindustry, CellaVision AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CellaVision AB Shiller PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, CellaVision AB's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where CellaVision AB's Shiller PE Ratio falls into.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
CellaVision AB's Shiller PE Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CellaVision AB's E10 for the quarter that ended in Jun. 2026 is calculated as:
For example, CellaVision AB's adjusted earnings per share data for the three months ended in Jun. 2026 was:
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
CellaVision AB (CHIX:CEVIS) has a Shiller PE Ratio of 25.80 as of Aug. 24, 2026. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on CellaVision AB and its competitors. This is 74% below median its historical median of 100.64. Over the past decade, CellaVision AB's Shiller PE Ratio has ranged from 22.81 to 184.21. According to the industry distribution chart, CellaVision AB ranks #184 out of 311 companies in the Medical Devices & Instruments industry, placing it in the top 59.2%.
Is CellaVision AB's Shiller PE Ratio too high?
CellaVision AB's current Shiller PE Ratio of 25.80 is 74% below median its 10-year median of 100.64. Over the past 10 years, this metric has ranged from a low of 22.81 to a high of 184.21. The Medical Devices & Instruments industry median Shiller PE Ratio is 27.00. CellaVision AB's value of 25.80 is 4.4% below this industry median. Based on the distribution chart, CellaVision AB ranks #184 out of 311 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, CellaVision AB has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does CellaVision AB's Shiller PE Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, CellaVision AB ranks #184 out of 311 companies for Shiller PE Ratio. This places CellaVision AB in the lower half of its industry. The industry median Shiller PE Ratio is 27.00. CellaVision AB's value of 25.80 is 4.4% below this benchmark. Historically, CellaVision AB's own Shiller PE Ratio has ranged from 22.81 to 184.21 over the past decade. While the company's 10-year median is 100.64 vs. the industry median of 27.00, CellaVision AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shiller PE Ratio for a Medical Devices & Instruments company?
The median Shiller PE Ratio among Medical Devices & Instruments companies is 27.00, based on 311 companies in the industry. Companies in the top quartile (top 25%) have a Shiller PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Shiller PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. CellaVision AB's current Shiller PE Ratio of 25.80 is 4.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shiller PE Ratio mean?
A high Shiller PE Ratio can signal that a stock is expensive relative to its fundamentals. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on CellaVision AB and its competitors. For the Medical Devices & Instruments industry, the median Shiller PE Ratio is 27.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CellaVision AB's current Shiller PE Ratio is 25.80, which is 74% below median its own 10-year median of 100.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CellaVision AB stock overvalued right now?
CellaVision AB (CHIX:CEVIS) has a current Shiller PE Ratio of 25.80. The stock's GF Value™ is kr187.70, compared to a current price of kr160.20 — trading 14.7% below its estimated fair value. The current Shiller PE Ratio is 25.80, which is 74% below median its 10-year median of 100.64 and 4.4% below the Medical Devices & Instruments industry median of 27.00. CellaVision AB's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shiller PE Ratio calculated?
Shiller PE Ratio is calculated from a company's financial statements. For CellaVision AB (CHIX:CEVIS), the current Shiller PE Ratio is 25.80 as of Aug. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CellaVision AB (CHIX:CEVIS) Overvalued in 2026?
Based on GuruFocus' analysis, CellaVision AB stock appears to be undervalued.
The current stock price of kr160.20 is trading 14.7% below its estimated GF Value™ of kr187.70.
Key valuation signals for CHIX:CEVIS:
Shiller PE Ratio: 25.80 (74% below median its 10-year median of 100.64)
GF Value™: kr187.70 vs. price of kr160.20 (14.7% below fair value)
Industry Position: 4.4% below the Medical Devices & Instruments median (#184 of 311)
No single metric tells the full story. See the CHIX:CEVIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CellaVision AB is engaged in developing and selling instruments, software, and reagents for blood and body fluid analysis. The company automates parts of the sample preparation process and replaces manual microscopes with instruments based on digital image analysis technology and artificial intelligence. The solutions contribute to more effective workflows and higher quality in laboratory medicine. The product offer consists of products and solutions for standardized laboratory diagnostics and improved performance for cellular image processing and systems for digital microscopy in hematology, consisting of reagents, instruments, and supplementary software and peripheral equipment.
97GF Score
Get the complete analysis for CHIX:CEVIS
Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:CEVIS has been successfully added to your 
